Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GNA15 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ACAP1 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
mRNA | KMT2D | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | ZNF775 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
mRNA | ZNF362 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
mRNA | ZNF493 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |